Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 1;318(6):F1315-F1326.
doi: 10.1152/ajprenal.00071.2020. Epub 2020 Apr 6.

Preeclampsia beyond pregnancy: long-term consequences for mother and child

Affiliations
Review

Preeclampsia beyond pregnancy: long-term consequences for mother and child

Hannah R Turbeville et al. Am J Physiol Renal Physiol. .

Abstract

Preeclampsia is defined as new-onset hypertension after the 20th wk of gestation along with evidence of maternal organ failure. Rates of preeclampsia have steadily increased over the past 30 yr, affecting ∼4% of pregnancies in the United States and causing a high economic burden (22, 69). The pathogenesis is multifactorial, with acknowledged contributions by placental, vascular, renal, and immunological dysfunction. Treatment is limited, commonly using symptomatic management and/or early delivery of the fetus (6). Along with significant peripartum morbidity and mortality, current research continues to demonstrate that the consequences of preeclampsia extend far beyond preterm delivery. It has lasting effects for both mother and child, resulting in increased susceptibility to hypertension and chronic kidney disease (45, 54, 115, 116), yielding lifelong risk to both individuals. This review discusses recent guideline updates and recommendations along with current research on these long-term consequences of preeclampsia.

Keywords: developmental origins; fetal programming; hypertension; kidney disease.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest, financial or otherwise, are declared by the authors.

References

    1. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 10: CD002252, 2007. doi:10.1002/14651858.CD002252.pub2. - DOI - PubMed
    1. Abalos E, Duley L, Steyn DW, Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 10: CD002252, 2018. doi:10.1002/14651858.CD002252.pub4. - DOI - PMC - PubMed
    1. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 286: H1389–H1393, 2004. doi:10.1152/ajpheart.00298.2003. - DOI - PubMed
    1. Alpoim PN, Gomes KB, Pinheiro MB, Godoi LC, Jardim LL, Muniz LG, Sandrim VC, Fernandes AP, Dusse LM. Polymorphisms in endothelial nitric oxide synthase gene in early and late severe preeclampsia. Nitric Oxide 42: 19–23, 2014. doi:10.1016/j.niox.2014.07.006. - DOI - PubMed
    1. Alsnes IV, Janszky I, Åsvold BO, Økland I, Forman MR, Vatten LJ. Maternal preeclampsia and androgens in the offspring around puberty: a follow-up study. PLoS One 11: e0167714, 2016. doi:10.1371/journal.pone.0167714. - DOI - PMC - PubMed

Publication types

MeSH terms